These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 15248906)

  • 1. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
    Lin J; Zhu MH; Qu JH; Li FM; Ni CR
    Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis B virus X protein inhibits hepatoma cell growth in vitro through p14(ARF)-dependent and p14(ARF)-independent pathways].
    Yu DH; Lin J; Qu JH; Zhu Z; Li FM; Ni CR; Zhu MH
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1089-93. PubMed ID: 19726330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of hepatitis B virus X gene and p53 on hepatocellular carcinoma cell growth].
    Lin J; Zhu MH; Zhu S; Qu JH; Li FM; Ni CR
    Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):43-7. PubMed ID: 12760803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells].
    Liu XH; Lin J; Cao XZ; Zheng JM; Chen Y; Zhu MH
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):825-30. PubMed ID: 15949399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
    Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
    Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interaction effect of p53 with HBV in hepatoma cell line SMMC-7721].
    Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):403-5. PubMed ID: 15268803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of cooperation of tumor suppressor p33(ING1b) with p53 gene in hepatocellular carcinoma].
    Zhu Z; Lin J; Qu JH; Li FM; Ni CR; Zhu MH
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1795-800. PubMed ID: 14642087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological effects of COOH-terminal amino acid deletions of hepatitis B virus X protein on hepatocellular carcinoma cell line Huh7].
    Liu XH; Zhu MH; Cao XZ; Zheng JM; Chen Y
    Ai Zheng; 2005 Oct; 24(10):1213-9. PubMed ID: 16219135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
    Oguey D; Dumenco LL; Pierce RH; Fausto N
    Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of HBV DNA replication and expression in 2.2.15 hepatoma cells infected with AFP-mediated HBX antisense RNA].
    Ma CH; Sun WS; Liu SX; Wang XY; Zhang LN; Cao YL; Han LH
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):291-4. PubMed ID: 12773245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HBx gene down-regulates miR-192 expression and inhibits apoptosis of human hepatoma cell line HepG2].
    Xie QH; He XX; Chang Y; Jiang X; Lin JS
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):857-60. PubMed ID: 22433310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
    Arima T; Nakao K; Nakata K; Ishikawa H; Ichikawa T; Hamasaki K; Ishii N; Eguchi K
    Int J Mol Med; 2002 Apr; 9(4):397-400. PubMed ID: 11891535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation.
    Zhang H; Shan CL; Li N; Zhang X; Zhang XZ; Xu FQ; Zhang S; Qiu LY; Ye LH; Zhang XD
    Acta Pharmacol Sin; 2008 Apr; 29(4):473-80. PubMed ID: 18358094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The inhibitory effects on hepatitis B virus replication by stable expression of DN mutants of hepatitis B virus X gene pRev X-GFP].
    Song JW; Lin JS; Kong XJ; Liang KH
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):392-4. PubMed ID: 15268799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of p53-p21/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinoma.
    Lee TK; Man K; Poon RT; Lo CM; Ng IO; Fan ST
    Oncol Rep; 2004 Jul; 12(1):25-31. PubMed ID: 15201954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
    Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
    Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
    Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
    Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
    Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.